Skip to content

Baudax Bio, Inc.

CIK 0001780097

← back to feed
Revenue (TTM)
$282K
+17.5% YoY Q3 Nov 2023
Net Income (TTM)
−$27.11M
−197.4% YoY Q3 Nov 2023
EPS Diluted (TTM)
−$95.60
+50.9% YoY Q3 Nov 2023
Gross Margin
-850.0%
Q3 Nov 2023
Operating Margin
-6,058.2%
Q3 Nov 2023
Net Margin
-9,614.2%
Q3 Nov 2023
Free Cash Flow (TTM)
−$30.05M
Q3 Nov 2023
Cash
$363K
Q3 Nov 2023
Total Debt
$4.23M
Q3 Nov 2023
Shares Outstanding
43.59M sh
Q3 Nov 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings